Steinkasserer A - Search Results

1

Soluble CD83 Triggers Resolution of Arthritis and Sustained Inflammation Control in IDO Dependent Manner.

Royzman D, Andreev D, Stich L, Rauh M, Bäuerle T, Ellmann S, Boon L, Kindermann M, Peckert K, Bozec A, Schett G, Steinkasserer A, Zinser E. Royzman D, et al. Among authors: steinkasserer a. Front Immunol. 2019 Apr 2;10:633. doi: 10.3389/fimmu.2019.00633. eCollection 2019. Front Immunol. 2019. PMID: 31001257 Free PMC article.

2

CD83 on dendritic cells: more than just a marker for maturation.

Lechmann M, Berchtold S, Hauber J, Steinkasserer A. Lechmann M, et al. Among authors: steinkasserer a. Trends Immunol. 2002 Jun;23(6):273-5. doi: 10.1016/s1471-4906(02)02214-7. Trends Immunol. 2002. PMID: 12072358 Review.

3

Role of CD83 in the immunomodulation of dendritic cells.

Lechmann M, Zinser E, Golka A, Steinkasserer A. Lechmann M, et al. Among authors: steinkasserer a. Int Arch Allergy Immunol. 2002 Oct;129(2):113-8. doi: 10.1159/000065883. Int Arch Allergy Immunol. 2002. PMID: 12403928 Review.

4

Prevention and treatment of experimental autoimmune encephalomyelitis by soluble CD83.

Zinser E, Lechmann M, Golka A, Lutz MB, Steinkasserer A. Zinser E, et al. Among authors: steinkasserer a. J Exp Med. 2004 Aug 2;200(3):345-51. doi: 10.1084/jem.20030973. J Exp Med. 2004. PMID: 15289503 Free PMC article.

5

CNI-1493 mediated suppression of dendritic cell activation in vitro and in vivo.

Zinser E, Turza N, Steinkasserer A. Zinser E, et al. Among authors: steinkasserer a. Immunobiology. 2004;209(1-2):89-97. doi: 10.1016/j.imbio.2004.04.004. Immunobiology. 2004. PMID: 15481144

6

The soluble form of CD83 dramatically changes the cytoskeleton of dendritic cells.

Kotzor N, Lechmann M, Zinser E, Steinkasserer A. Kotzor N, et al. Among authors: steinkasserer a. Immunobiology. 2004;209(1-2):129-40. doi: 10.1016/j.imbio.2004.04.003. Immunobiology. 2004. PMID: 15481147

7

CD83 is a dimer: Comparative analysis of monomeric and dimeric isoforms.

Lechmann M, Kotzor N, Zinser E, Prechtel AT, Sticht H, Steinkasserer A. Lechmann M, et al. Among authors: steinkasserer a. Biochem Biophys Res Commun. 2005 Apr 1;329(1):132-9. doi: 10.1016/j.bbrc.2005.01.114. Biochem Biophys Res Commun. 2005. PMID: 15721284

8

Determination of the inhibitory activity and biological half-live of soluble CD83: comparison of wild type and mutant isoforms.

Zinser E, Lechmann M, Golka A, Hock B, Steinkasserer A. Zinser E, et al. Among authors: steinkasserer a. Immunobiology. 2006;211(6-8):449-53. doi: 10.1016/j.imbio.2006.05.009. Epub 2006 Jul 5. Immunobiology. 2006. PMID: 16920484

9

CD83 knockdown in monocyte-derived dendritic cells by small interfering RNA leads to a diminished T cell stimulation.

Prechtel AT, Turza NM, Theodoridis AA, Steinkasserer A. Prechtel AT, et al. Among authors: steinkasserer a. J Immunol. 2007 May 1;178(9):5454-64. doi: 10.4049/jimmunol.178.9.5454. J Immunol. 2007. PMID: 17442926

10

Published studies reporting the efficacy of soluble CD83 in vitro as well as in vivo.

Zinser E, Steinkasserer A. Zinser E, et al. Among authors: steinkasserer a. Immunol Lett. 2008 Jan 15;115(1):18-9. doi: 10.1016/j.imlet.2007.10.011. Epub 2007 Nov 20. Immunol Lett. 2008. PMID: 18054088 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

174 results

Search Page